Camelot Portfolios’s VeriSign VRSN Stock Holding History

Camelot Portfolios’s Portfolio VRSN Stock Details VRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-543	Closed	-$132K	–	545
2025 Q4	$132K	Buy	+543	New	+$136K	0.08%	211
2025 Q2	–	Sell	-1,385	Closed	-$352K	–	222
2025 Q1	$352K	Buy	+1,385	New	+$315K	0.22%	131

Other funds holding VRSN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Camelot Portfolios's VRSN Position: Q1 2026 in Review

Camelot Portfolios sold out of VeriSign (VRSN) in Q1 2026, closing a stake of 543 shares — an estimated $132K sold.

Camelot Portfolios first reported a position in VRSN in Q1 2025 and held it in 2 quarters. The position peaked at $352K in Q1 2025. 849 funds tracked by Wall St. Rank hold VRSN as of Q1 2026.

Camelot Portfolios reported no remaining VeriSign position as of Q1 2026 after selling out during the quarter.
Camelot Portfolios sold 543 VeriSign shares in Q1 2026, an estimated $132K.
Camelot Portfolios first reported a position in VeriSign in Q1 2025 and held it in 2 quarters.
Camelot Portfolios's VeriSign position peaked at $352K in Q1 2025.
849 funds tracked by Wall St. Rank held VeriSign as of Q1 2026.

Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.